A weekly trade journal catering to the Indian chemical industry
backBack

calendar 13 January, 2026 16:45:48 IST

Jubilant Biosys doubles early chemistry scale-up capacity with new facility in Noida

Article image

Jubilant Biosys Ltd., a wholly owned subsidiary of Jubilant Pharmova Ltd., and a global CRDMO operating from five sites across India and Europe, has announced the opening of a new discovery and preclinical facility at Noida (Delhi NCR), doubling its overall chemistry capacity for discovery research and scale-up projects.

The “multimillion-dollar” facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants, meeting growing demand, in particular for fee-for-service (FFS) contracts.

“We have grown rapidly over the past year, well above the wider market, by expanding our FFS offerings, which enable innovators to advance discovery projects with lower risk. With improving funding conditions, we anticipate even higher demand next year, and this new facility doubles our existing capabilities. From a client perspective, we can now provide faster discovery delivery and integrated scale-up, with projects seamlessly transferred to our GMP facilities ready for any IND filing and commercial phases” commented Mr. Giuliano Perfetti, CEO, Jubilant Biosys.  

The new Noida facility offers biotech and pharma partners a fully unified route from discovery to scale-up, augmenting the company’s existing Chemistry Research Innovation Centre (CRIC) in Greater Noida (Delhi). “Collectively, this brings the total numbers of scientists across the business to more than 1,300, with the new facility adding multiple manufacturing lines and having already onboarded several new clients,” the company said in a press note.

Designed to handle quantities from hundreds of grams up to 25-kg, the new small-molecule hub combines two pilot plant blocks with co-located discovery labs. It features 20,000 sq. ft. of R&D space as well as 15 reactors spanning a variety of sizes from 20L through to 250L. The facility has been designed with a potential to be expanded multi-fold in future and has room to quadruple capacity as client demand grows.

article image
calender image

calender image 9 November, 2026 20:19:59 IST

Will India’s butadiene paradox resolve through integrated C4 value chain development?

India is at an important turning point in the development of its butadiene value chain. For years, the country...
article image

calender image 13 November, 2026 17:00:07 IST

Navin Fluorine’s new Surat HFC unit begins commercial operations

Mumbai-based Navin Fluorine International has begun commercial operations at its new hydrofluorocarbon (HFC) plant at Surat in Gujarat....

PRINT EDITION

View Past Issues

Search For

Exhibitions & Conferences

ChemExpo IndiaChemProTechChemLogistics India

Watch

KKBangEchemiGPCA ForumCPHI PMEC INDIA